Pyxis Oncology Inc. (PYXS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Pyxis Oncology Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$1.98
+7.61% today
Market cap
$220M
Overall quality
—
Kronos AI 30-day
+34.6%
8 of 8 simulated paths end higher
Pyxis Oncology Inc. (PYXS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $220M. It trades at $1.98, up 7.61% today. 7 analysts' average target of $9.00 implies +354.5% from today's price. Kronos AI's 30-day forecast is +34.6% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $9.00 |
| Low – high | $6.00 – $19.00 |
| Analysts | 7 |
| Upside to average | +354.5% |
Kronos AI 30-day forecast
| Expected close | $2.48 (+34.6%) |
| Likely range | +26.8% … +49.3% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.